2023 AAO 指南：睑缘炎
浏览量 : 7692
发布时间: 2024-01-13
英文标题: Blepharitis PPP 2023
作者: 美国眼科学会 AAO
出处: Ophthalmology . 2024 Feb 13
内容介绍:
The Blepharitis PPP was sent for review in July 2023 to improve the quality of the guideline, to gatherfeedback on the draft recommendations, and to assess feasibility for and applicability to the target audience,including assessing the facilitators and barriers to implementing recommendations (e.g., U.S.ophthalmologists and other important groups, including patients, other physicians, internationalophthalmologists, research organizations, ophthalmological organizations, and experts in the field). The PPPwas sent for review to the following patient organizations to solicit the views and preferences of patients andthe public: Consumers United for Evidence-Based Healthcare, American Foundation for the Blind,Foundation Fighting Blindness, Lighthouse Guild, National Federation of the Blind, and Prevent Blindness.All those who were returning comments were required to provide disclosure of relevant relationships withindustry to have their comments considered (indicated with an asterisk below). Members of theCornea/External Disease Preferred Practice Pattern Panel reviewed these comments and determined revisionsto the document.
The Blepharitis PPP was sent for review in July 2023 to improve the quality of the guideline, to gatherfeedback on the draft recommendations, and to assess feasibility for and applicability to the target audience,including assessing the facilitators and barriers to implementing recommendations (e.g., U.S.ophthalmologists and other important groups, including patients, other physicians, internationalophthalmologists, research organizations, ophthalmological organizations, and experts in the field). The PPPwas sent for review to the following patient organizations to solicit the views and preferences of patients andthe public: Consumers United for Evidence-Based Healthcare, American Foundation for the Blind,Foundation Fighting Blindness, Lighthouse Guild, National Federation of the Blind, and Prevent Blindness.All those who were returning comments were required to provide disclosure of relevant relationships withindustry to have their comments considered (indicated with an asterisk below). Members of theCornea/External Disease Preferred Practice Pattern Panel reviewed these comments and determined revisionsto the document.